Oculis Aktie
| 15,33USD | 0,04USD | 0,26% |
WKN DE: A3D8QG / ISIN: CH1242303498
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 59,81 |
| LSP Management Group BV | 12,76 |
| Brunnur Ventures GP ehf | 5,60 |
| Shanghai Bioveda Investment Management Consulting Co. Ltd. | 4,96 |
| Pivotal Bioventure Partners Investment Advisor LLC | 4,87 |
| Martijn Kleijwegt | 4,78 |
| Novartis AG | 4,10 |
| Tekla Capital Management LLC | 4,05 |
| Pivotal Bioventure Partners Investment Advisor LLC | 3,82 |
| Glazer Capital LLC | 3,01 |
| Riad Sherif, MD, MBA | 2,10 |
| abrdn, Inc. | 1,97 |
| Periscope Capital, Inc. | 1,86 |
| Millennium Management LLC | 1,42 |
| Macquarie Group Ltd. (13F Subfiler) | 1,21 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Personal am Ende des Jahres | 2 | 28 | 36 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,00 | 0,00 | 0,00 |
Bilanz (in Mio. USD) - Aktiva
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Summe Umlaufvermögen | 1 | 26 | 120 |
| Summe Anlagevermögen | 128 | 14 | 16 |
| Summe Aktiva | 128 | 40 | 136 |
Bilanz (in Mio. USD) - Passiva
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Gesamtverschuldung/ -verbindlichkeiten | 0 | 133 | 1 |
| Summe Fremdkapital | 8 | 146 | 25 |
| Summe Eigenkapital | 121 | -106 | 111 |
| Summe Passiva | 128 | 40 | 136 |
Adresse
| Bahnhofstrasse 7, 6300 Zug | |
| Telefon | +41 (58) 810-01-82 |
| Internet | http://oculis.com |
Management
|
Anthony Adam Rosenberg
Chairman |
|
Arshad M. Khanani
Director |
|
Bastian Dehmel
Chief Development Officer |
|
Christina Maria Ackermann
Independent Director |
|
Daniel S. Char
Chief Legal Officer |
|
Geraldine O'Keeffe
Independent Director |
|
Lionel Carnot
Independent Director |
|
Martijn Kleijwegt
Independent Director |
|
Páll Ragnar Jóhannesson
Chief Business Officer |
|
Ramin Tadayoni
Chief Scientific Officer |
|
Rebecca Weil
Chief Commercial Officer |
|
Riad Sherif
Chief Executive Officer & Director |
|
Robert K. Warner
Director |
|
Sharon Klier
Chief Development Officer |
|
Snehal Shah
President-Research & Development |
|
Sylvia Cheung
Chief Financial Officer |
|
Virginia R. Dean
Chief Human Resources Officer |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
